Newsletter Vol. 3, No. 47
Summary
New Jersey Medicaid program is deleting specific pharmaceutical drugs from the Federal Medicaid Upper Limits (MAC) list effective June, July, and August. Affected drugs include Amiloride Hydrochloride, Butabarbital Sodium, Dexchlorpheniramine Maleate, Chloramphenicol, Potassium Chloride, Sulfacetamide Sodium, and Aspirin/Oxycodone combinations. Reimbursement will now be based on the lower of AWP minus applicable discounts plus dispensing fee or Usual and Customary Charge for all New Jersey Medicaid programs (Medicaid, PAAD, GAP, CFDP, GSHP, and ADDP).
Get alerts when payers change rules like this one
We check New Jersey Medicaid and other payers every day and email you when a change matches your specialty and state.